N/A
N=182
A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer
Lung Cancer · Esophageal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT02239328 ↗Enrolled (actual)
182
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcome: Primary: Patient Reported Outcomes Measurement Information System (PROMIS) Scores. — 43.05; 51.51; 48.64; 50.74 units on a scale — p=<0.05
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Virginia
- Primary completion
- Jun 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Reported Outcomes Measurement Information System (PROMIS) Scores. |
43.05; 51.51; 48.64; 50.74; 51.45 | <0.05 sig |
Summary
This survey study is looking to determine if patient reported outcomes(using the PROMIS survey) will vary according to the presence of recurrent or metastatic lung or esophageal cancer.
Eligibility Criteria
Inclusion Criteria
- ≥18 years of age
- Suspected or Known diagnosis of lung or esophageal cancer
- Willing and able to complete questionnaires
Exclusion Criteria
- Subjects unwilling to provide informed consent
- Subjects unwilling or unable to answer the questionnaires
Data sourced from ClinicalTrials.gov (NCT02239328). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.